{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:30:27Z","timestamp":1790605827592,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jinf.2025.106635","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:56:05Z","timestamp":1760730965000},"page":"106635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal Initiative"],"prefix":"10.1016","volume":"91","author":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-9844","authenticated-orcid":false,"given":"Dominque A.","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-0134","authenticated-orcid":false,"given":"Ener \u00c7agri","family":"Dinleyici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-2335","authenticated-orcid":false,"given":"Ian","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6650-3960","authenticated-orcid":false,"given":"William P.","family":"Hausdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lucidarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-9446","authenticated-orcid":false,"given":"Marco A.P.","family":"S\u00e1fadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6127-1435","authenticated-orcid":false,"given":"Vinny","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-3174","authenticated-orcid":false,"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2025.106635_bib1","series-title":"Meningococcal disease (Neisseria meningitidis infection)","author":"Rausch-Phung","year":"2025"},{"issue":"1","key":"10.1016\/j.jinf.2025.106635_bib2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1186\/s12889-022-13342-2","article-title":"Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review","volume":"22","author":"Shen","year":"2022","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.jinf.2025.106635_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jinf.2023.10.011","article-title":"Meningococcal disease in the Middle East: a report from the Global Meningococcal Initiative","volume":"88","author":"l-Abri","year":"2024","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jinf.2025.106635_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jinf.2022.10.022","article-title":"Meningococcal disease in North America: updates from the Global Meningococcal Initiative","volume":"85","author":"Asturias","year":"2022","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jinf.2025.106635_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jinf.2021.11.016","article-title":"Surveillance and control of meningococcal disease in the COVID-19 era: a Global Meningococcal Initiative review","volume":"84","author":"Alderson","year":"2022","journal-title":"J Infect"},{"issue":"18","key":"10.1016\/j.jinf.2025.106635_bib6","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","article-title":"The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease","volume":"29","author":"Harrison","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jinf.2025.106635_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106335","article-title":"Global Meningococcal Initiative: insights on antibiotic resistance, control strategies and advocacy efforts in Western Europe","volume":"89","author":"Borrow","year":"2024","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jinf.2025.106635_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2025.106635_bib9","series-title":"Evolution of meningococcal disease","article-title":"Evolution of meningococcal disease epidemiology in the US army","author":"Brundage","year":"1987"},{"key":"10.1016\/j.jinf.2025.106635_bib10","unstructured":"UKHSA invasive meningococcal disease in England annual report 2023\/4. \u3008https:\/\/www.gov.uk\/government\/publications\/meningococcal-disease-laboratory-confirmed-cases-in-england-2023-to-2024\/invasive-meningococcal-disease-in-england-annual-laboratory-confirmed-reports-for-epidemiological-year-2023-to-2024#:\u223c:text=MenC%20cases%20remained%20low%2C%20with,%2F16%20(table%201)\u3009 [Last accessed May 2025]."},{"issue":"1","key":"10.1016\/j.jinf.2025.106635_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/cid\/cix215","article-title":"Large cluster of Neisseria meningitidis urethritis in Columbus, Ohio, 2015","volume":"65","author":"Bazan","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106635_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s40121-022-00620-0","article-title":"Meningococcal disease and immunization activities in Hajj and Umrah pilgrimage: a review","volume":"11","author":"Badur","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"8657","key":"10.1016\/j.jinf.2025.106635_bib13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(89)90439-X","article-title":"Intercontinental spread of an epidemic group A Neisseria meningitidis strain","volume":"2","author":"Moore","year":"1989","journal-title":"Lancet"},{"issue":"37","key":"10.1016\/j.jinf.2025.106635_bib14","doi-asserted-by":"crossref","first-page":"20581","DOI":"10.2807\/1560-7917.ES2013.18.37.20581","article-title":"Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011","volume":"18","author":"Memish","year":"2013","journal-title":"Eur Surveill"},{"issue":"4","key":"10.1016\/j.jinf.2025.106635_bib15","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s40121-021-00467-x","article-title":"The epidemiology of invasive meningococcal disease in the Kingdom of Saudi Arabia: a narrative review with updated analysis","volume":"10","author":"Badur","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"9248","key":"10.1016\/j.jinf.2025.106635_bib16","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0140-6736(00)03502-9","article-title":"Serogroup W135 meningococcal disease in Hajj pilgrims","volume":"356","author":"Taha","year":"2000","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.jinf.2025.106635_bib17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2016.02.014","article-title":"Global epidemiology of capsular group W meningococcal disease (1970-2015): multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex","volume":"34","author":"Mustapha","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jinf.2025.106635_bib18","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1017\/S0950268814001149","article-title":"Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America","volume":"142","author":"Abad","year":"2014","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2025.106635_bib19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.jinf.2025.106635_bib20","first-page":"514","article-title":"Cases of meningococcal disease associated with travel to Saudi Arabia for Umrah Pilgrimage \u2014 United States, United Kingdom, and France, 2024","volume":"73","author":"Vachon","year":"2024","journal-title":"MMWR"},{"key":"10.1016\/j.jinf.2025.106635_bib21","unstructured":"CDC Health Alert Network. Increase in invasive serogroup Y meningococcal disease in the United States. \u3008https:\/\/www.cdc.gov\/han\/2024\/han00505.html\u3009 [Last accessed May 2025]."},{"key":"10.1016\/j.jinf.2025.106635_bib22","unstructured":"Lahra MM, Van Hal S, Hutabarat SN, Hogan TR. Communicable diseases intelligence: Australian gonococcal surveillance programme, 1 January to 31 March, 2024. \u3008https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/A005BA6FD1F9ACD4CA258BFC0001FE0A\/$File\/cdi-2025-49-001.pdf\u3009 [Last accessed May 2025]."},{"key":"10.1016\/j.jinf.2025.106635_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1186\/s12879-024-09547-y","article-title":"Recent increase in atypical presentations of invasive meningococcal disease in France","volume":"24","author":"Taha","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106635_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad615","article-title":"Not only meningitis but also epiglottitis: an emerging clinical presentation of invasive meningococcal disease","volume":"11","author":"Deghmane","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2025.106635_bib25","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1097\/INF.0000000000003660","article-title":"Impact of COVID-19 containment strategies and meningococcal conjugate ACWY vaccination on meningococcal carriage in adolescents","volume":"41","author":"McMillan","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.jinf.2025.106635_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/INF.0000000000004622","article-title":"The prevalence, serogroup distribution and risk factors of meningococcal carriage in children, adolescents and young adults in Turkey Meningo-Carr-TR study PART 3: COVID-19 pandemic situation","volume":"44","author":"Kizil","year":"2025","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.jinf.2025.106635_bib27","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S1473-3099(20)30239-5","article-title":"Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys","volume":"20","author":"Mbaeyi","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2025.106635_bib28","doi-asserted-by":"crossref","first-page":"1649.e1","DOI":"10.1016\/j.cmi.2022.07.004","article-title":"Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme","volume":"28","author":"Carr","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.jinf.2025.106635_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8111675","article-title":"Herd protection against meningococcal disease through vaccination","volume":"8","author":"Clark","year":"2020","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.jinf.2025.106635_bib30","doi-asserted-by":"crossref","first-page":"e1661","DOI":"10.1093\/cid\/ciaa1244","article-title":"First real-world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease: prospective enhanced national surveillance, England","volume":"73","author":"Ladhani","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"34","key":"10.1016\/j.jinf.2025.106635_bib31","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1016\/j.vaccine.2023.06.078","article-title":"Surveillance of Neisseria meningitidis carriage four years after menACWY vaccine implementation in the Netherlands reveals decline in vaccine-type and rise in genogroup e circulation","volume":"41","author":"Miellet","year":"2023","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jinf.2025.106635_bib32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jinf.2020.07.034","article-title":"Methods to evaluate serogroup B meningococcal vaccines: from predictions to real-world evidence","volume":"81","author":"Borrow","year":"2020","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2025.106635_bib33","article-title":"Exploring the sequence diversity and surface expression of factor H-binding protein among invasive serogroup B meningococcal strains from selected European countries","volume":"20","author":"Clark","year":"2024","journal-title":"Hum Vaccines Immunother"},{"issue":"10102","key":"10.1016\/j.jinf.2025.106635_bib34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2025.106635_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2023.05.021","article-title":"4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation","volume":"87","author":"Wang","year":"2023","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2025.106635_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae726","article-title":"Long-term 4CMenB vaccine effectiveness against gonococcal infection at four years post-program implementation: observational case-control study","volume":"12","author":"Wang","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2025.106635_bib37","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1016\/S1473-3099(24)00031-8","article-title":"Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK","volume":"24","author":"Ladhani","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2025.106635_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106225","article-title":"Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: a systematic review and meta-analysis","volume":"89","author":"Wang","year":"2024","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.jinf.2025.106635_bib39","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S1473-3099(21)00744-1","article-title":"Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis","volume":"22","author":"Whittles","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2025.106635_bib40","unstructured":"Clinicaltrials.gov (VAN00010). \u3008https:\/\/clinicaltrials.gov\/study\/NCT06128733?tab=history&a=1\u3009 [Accessed August 2025]."},{"issue":"4","key":"10.1016\/j.jinf.2025.106635_bib41","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-069926","article-title":"October 2024 ACIP meeting update: influenza, COVID-19, RSV, and other vaccines","volume":"155","author":"Gaviria-Agudelo","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2025.106635_bib42","article-title":"Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling study","volume":"44","author":"Shoukat","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"10484","key":"10.1016\/j.jinf.2025.106635_bib43","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(25)00046-7","volume":"405","author":"Diallo","year":"2025","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jinf.2025.106635_bib44","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1056\/NEJMoa2214924","article-title":"Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia","volume":"388","author":"Haidara","year":"2023","journal-title":"NEJM"},{"key":"10.1016\/j.jinf.2025.106635_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41541-024-00935-8","article-title":"A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine","volume":"9","author":"Kim","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jinf.2025.106635_bib46","series-title":"Presented at 24th international pathogenic neisseria conference (IPNC2025), 30 March\u20134 April 025, Florence, Italy (Poster P106)","article-title":"Phase 2\/3 study of the EuBiologics pentavalent meningococcal ACWYX conjugate vaccine compared to MENVEO\u00ae or Nimenrix\u00ae in healthy infants, children, adolescents, and adults in Mali and The Gambia (2025)","author":"Haidara","year":"2025"},{"key":"10.1016\/j.jinf.2025.106635_bib47","unstructured":"Uruguay. Ministry of Health. Vaccination against meningococcal disease. \u3008https:\/\/www.gub.uy\/ministerio-salud-publica\/comunicacion\/publicaciones\/vacunacion-contra-enfermedad-meningococica-uruguay-documento-tecnico\u3009 [Last assessed August 2025]."},{"key":"10.1016\/j.jinf.2025.106635_bib48","unstructured":"CDC. Meningococcal vaccine recommendations. \u3008https:\/\/www.cdc.gov\/meningococcal\/hcp\/vaccine-recommendations\/index.html\u3009 [Last accessed, May 2025]."},{"key":"10.1016\/j.jinf.2025.106635_bib49","unstructured":"ECDC. Meningococcal disease: recommended vaccinations. \u3008https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=48&SelectedCountryIdByDisease=-1\u3009 [Last accessed May 2025]."},{"key":"10.1016\/j.jinf.2025.106635_bib50","unstructured":"UKHSA. Meningococcal green book chapter. \u3008https:\/\/assets.publishing.service.gov.uk\/media\/628363d6e90e071f62029bb9\/Meningococcal-greenbook-chapter-22_17May2022.pdf\u3009 [Last accessed May 2025]."},{"key":"10.1016\/j.jinf.2025.106635_bib51","unstructured":"Centers for Disease Control and Prevention (CDC). Meningococcal disease surveillance. \u3008https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html\u3009 [Last accessed May 2025]."},{"issue":"1","key":"10.1016\/j.jinf.2025.106635_bib52","article-title":"Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database","volume":"18","author":"Weil-Oliver","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jinf.2025.106635_bib53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12879-018-3119-4","article-title":"Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature","volume":"18","author":"Lesourd","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106635_bib54","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jemermed.2010.05.025","article-title":"Meningococcal epiglottitis in a diabetic adult patient: a case report","volume":"43","author":"Richardson","year":"2012","journal-title":"J Emerg Med"},{"issue":"23","key":"10.1016\/j.jinf.2025.106635_bib55","doi-asserted-by":"crossref","first-page":"1900070","DOI":"10.2807\/1560-7917.ES.2019.24.23.1900070","article-title":"Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015","volume":"24","author":"Lawler","year":"2019","journal-title":"Eur Surveill"},{"issue":"16","key":"10.1016\/j.jinf.2025.106635_bib56","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.16.2400673","article-title":"Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023","volume":"30","author":"Heymer","year":"2025","journal-title":"Eurosurveillance"},{"issue":"21","key":"10.1016\/j.jinf.2025.106635_bib57","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","article-title":"Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2025.106635_bib58","unstructured":"Public Health France. \u3008https:\/\/www.santepubliquefrance.fr\/content\/download\/615086\/4239954?version=2\u3009 [Last accessed May 2025]."},{"key":"10.1016\/j.jinf.2025.106635_bib59","unstructured":"ECDC. Invasive meningococcal disease - annual epidemiological report for 2022. \u3008https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/invasive-meningococcal-disease-annual-epidmeiological-report-2022.pdf\u3009 [Last accessed May 2025]."},{"key":"10.1016\/j.jinf.2025.106635_bib60","unstructured":"MRF. World meningitis day impact report. \u3008https:\/\/worldmeningitisday.org\/wp-content\/uploads\/2025\/07\/BIG_12224_WMD24_ImpactReport_WEB.pdf\u3009 [Last accessed September 2025]."},{"issue":"6","key":"10.1016\/j.jinf.2025.106635_bib61","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/hv.24129","article-title":"Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future","volume":"9","author":"Holst","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.jinf.2025.106635_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","article-title":"The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations","volume":"18","author":"Acevedo","year":"2019","journal-title":"Expert Rev Vaccin"},{"issue":"1","key":"10.1016\/j.jinf.2025.106635_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/vaccines7010005","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in new zealand: a retrospective cohort study","volume":"7","author":"Paynter","year":"2019","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.jinf.2025.106635_bib64","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31742","article-title":"Association of Group B meningococcal vaccine receipt with reduced gonorrhea incidence among university students","volume":"6","author":"Robison","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.jinf.2025.106635_bib65","doi-asserted-by":"crossref","first-page":"e1341","DOI":"10.1093\/cid\/ciac436","article-title":"Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in southern California","volume":"76","author":"Bruxvoort","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2025.106635_bib66","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/OLQ.0000000000001793","article-title":"Healthy vaccinee bias and MenB-FHbp vaccine effectiveness against gonorrhea","volume":"50","author":"Abara","year":"2023","journal-title":"Sex Transm Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344532500235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344532500235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:28:12Z","timestamp":1769034492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344532500235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S016344532500235X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106635","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal Initiative","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106635"}}